We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-16.07%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.09B
AUM Growth
-$461M
Cap. Flow
+$404M
Cap. Flow %
13.07%
Top 10 Hldgs %
27.53%
Holding
139
New
26
Increased
37
Reduced
15
Closed
17

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$72.8M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$58.7M
3
CRWD icon
CrowdStrike
CRWD
+$55.7M
4
DT icon
Dynatrace
DT
+$36.1M
5
DHI icon
D.R. Horton
DHI
+$33.2M

Top Sells

Rank Stock Value
1
MYOV
Myovant Sciences Ltd.
MYOV
+$37.3M
2
TTD icon
Trade Desk
TTD
+$32.3M
3
PANW icon
Palo Alto Networks
PANW
+$30.4M
4
IAA
IAA, Inc. Common Stock
IAA
+$28.7M
5
PAYC icon
Paycom
PAYC
+$26.5M

Sector Composition

Rank Sector Weight
1 Healthcare 44.32%
2 Technology 23.01%
3 Industrials 9.93%
4 Consumer Discretionary 5.91%
5 Utilities 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
26
Collegium Pharmaceutical
COLL
$1.17B
$39.6M 1.28%
2,427,976
– –
SMAR
27
DELISTED
Smartsheet Inc.
SMAR
$39.3M 1.27%
947,000
-28,000
-3% -$1.27M
ARGX icon
28
argenx
ARGX
$54.6B
$39.2M 1.27%
297,300
– –
BEP icon
29
Brookfield Renewable
BEP
$9.9B
$38.9M 1.26%
1,719,249
+7,506
+0.4% +$190K
CCI icon
30
Crown Castle
CCI
$33.4B
$38.4M 1.24%
265,900
-57,200
-18% -$8.53M
GWPH
31
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$38.2M 1.24%
436,000
– –
POOL icon
32
Pool Corp
POOL
$6.95B
$36.6M 1.19%
186,000
+1,000
+0.5% +$213K
IPHI
33
DELISTED
INPHI CORPORATION
IPHI
$35.6M 1.15%
450,000
– –
IDXX icon
34
Idexx Laboratories
IDXX
$44.1B
$34.6M 1.12%
143,000
+40,100
+39% +$10.5M
MNTA
35
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$33M 1.07%
1,212,000
-24,000
-2% -$668K
W icon
36
Wayfair
W
$11.9B
$30.6M 0.99%
573,000
– –
NBIX icon
37
Neurocrine Biosciences
NBIX
$18.7B
$30.6M 0.99%
353,000
– –
W icon
38
CALL
Wayfair
W
$11.9B
$30M 0.97%
+250,000
New +$19.1M
TECX
39
Tectonic Therapeutic
TECX
$538M
$29.6M 0.96%
158,776
+50,000
+46% +$11.8M
MYOK
40
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$29.1M 0.94%
621,000
– –
ODFL icon
41
Old Dominion Freight Line
ODFL
$44.2B
$28M 0.91%
427,000
+5,800
+1% +$385K
ROL icon
42
Rollins
ROL
$18.5B
$27.9M 0.9%
+1,159,500
New +$28.6M
APTV icon
43
Aptiv
APTV
$12.3B
$27.4M 0.89%
556,500
+287,800
+107% +$22.6M
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
$27.3M 0.89%
535,000
– –
BPMC
45
DELISTED
Blueprint Medicines
BPMC
$27M 0.87%
462,000
– –
VRNS icon
46
Varonis Systems
VRNS
$4.58B
$26.7M 0.87%
1,260,000
– –
KALA icon
47
KALA BIO
KALA
$13.6M
$26M 0.84%
+1,182
New +$18.9M
RNG icon
48
RingCentral
RNG
$4.48B
$25.6M 0.83%
+121,000
New +$24.9M
TREX icon
49
Trex
TREX
$4.56B
$24M 0.78%
598,000
– –
QURE icon
50
uniQure
QURE
$2.93B
$23.7M 0.77%
500,000
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Eventide Asset Management held 139 positions worth $3.09B, down 13% from $3.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management deployed $404M of net new capital in Q1 2020, opening 26 new positions and adding to 37 existing holdings. Its largest new stake was CrowdStrike: 3,948,000 shares worth $55M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Myovant Sciences Ltd., an estimated $37.3M trimmed.

  • Eventide Asset Management's largest Q1 2020 buy was CrowdStrike: 3,948,000 shares worth $55M.
  • Eventide Asset Management added most to Exact Sciences in Q1 2020, an estimated $72.8M increase.
  • Eventide Asset Management's biggest Q1 2020 reduction was Myovant Sciences Ltd., cutting an estimated $37.3M.
  • Eventide Asset Management fully exited IAA, Inc. Common Stock in Q1 2020, selling an estimated $28.7M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $3.09B portfolio in Q1 2020.
  • Eventide Asset Management opened 26 new positions and closed 17 in Q1 2020.
  • Eventide Asset Management's portfolio value fell 13% quarter-over-quarter to $3.09B.

Based on Eventide Asset Management's 13F filing for Q1 2020, filed 15 May 2020.